Recently, it was demonstrated that HER2 is overexpressed in ∼30% of primary locally advanced rectal adenocarcinoma, clinically staged as Union for International Cancer Control (UICC) stages II and III [21]. This evidence concerns the gene ERBB2 and rectum adenocarcinoma.